- XenoPort (NASDAQ:XNPT +0.7%) Q4 results: Revenues: $7.1M (+144.8%); COGS: $0.5M (-16.7%); R&D Expense: $7.2M (+94.6%); SG&A: $17M (-3.4%); Operating Loss: ($17.6M) (+7.9%); Net Loss: ($17.7M) (+7.3%); Loss Per Share: ($0.28) (+30.0%).
- FY2014 results: Revenues: $46.9M (+486.3%); COGS: $2.1M (+75.0%); R&D Expense: $23.7M (-28.8%); SG&A: $70.2M (+18.8%); Operating Loss: ($49.1M) (+42.6%); Net Loss: ($49.3M) (+42.6%); Loss Per Share: ($0.81) (+55.2%); Quick Assets: $102.1M (+73.9%).
- 2015 Guidance: HORIZANT net product sales: $39M - 43M; net use of cash: $75M - 85M.